SGK
SGK (serine/threonine-protein kinase) is important in activating certain potassium, sodium, and chloride channels.
Products Related to SGK(11)
- GC15441GSK 650394CAS: 890842-28-1Purity: >99.50%
GSK 650394 is an effective selective inhibitor of serum and glucocorticoid-regulated kinase-1 (SGK1), with IC 50 values of 62nM and 103nM for SGK1 and SGK2, respectively.
- GC35978EMD638683 S-FormCAS: 1184940-46-2Purity: >99.50%
EMD638683 (S-Form) is a SGK1 inhibitor with an IC50 of >300 nM.
- GC38755CKI-7CAS: 120615-25-0Purity: >99.00%
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases.
- GC39426PROTAC SGK3 degrader-1CAS: 2381320-35-8Purity: >99.00%
PROTAC SGK3 degrader-1 (SGK3-PROTAC1), is a potent SKG3 degrader based on von Hippel-Lindau ligand. PROTAC SGK3 degrader-1 (0.3 μM) induces 50% degradation of endogenous SGK3 within 2 hours, with maximal 80% degradation observed within 8 hours, accompanied by a loss of phosphorylation of NDRG1 (an SGK3 substrate).
- GC73088SGK1-IN-3 hydrochloridePurity: >96.00%
SGK1-IN-3 drochloride (compound 3a) is a potent and orally active inhibitor of SGK1.
- GC73111HaloPROTAC-ECAS: 2365478-58-4Purity: >99.00%
HaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC15441 | GSK 650394 | 890842-28-1 | >99.50% | |
GSK 650394 is an effective selective inhibitor of serum and glucocorticoid-regulated kinase-1 (SGK1), with IC 50 values of 62nM and 103nM for SGK1 and SGK2, respectively. | ||||
| GC17986 | EMD638683 | 1181770-72-8 | >99.50% | |
EMD638683 is a selective serum and glucocorticoid-induced kinase 1 (SGK1) inhibitor (IC 50 =3μM). | ||||
| GC30673 | SGK1-IN-1 | 1279829-87-6 | >98.50% | |
SGK1-IN-1 is a highly active and selective inhibitor of SGK-1, with an IC50 of 1 nM. | ||||
| GC35977 | EMD638683 R-Form | 1184940-47-3 | >99.50% | |
EMD638683 R-Form is the R-form of EMD638683. | ||||
| GC35978 | EMD638683 S-Form | 1184940-46-2 | >99.50% | |
EMD638683 (S-Form) is a SGK1 inhibitor with an IC50 of >300 nM. | ||||
| GC38755 | CKI-7 | 120615-25-0 | >99.00% | |
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases. | ||||
| GC39426 | PROTAC SGK3 degrader-1 | 2381320-35-8 | >99.00% | |
PROTAC SGK3 degrader-1 (SGK3-PROTAC1), is a potent SKG3 degrader based on von Hippel-Lindau ligand. PROTAC SGK3 degrader-1 (0.3 μM) induces 50% degradation of endogenous SGK3 within 2 hours, with maximal 80% degradation observed within 8 hours, accompanied by a loss of phosphorylation of NDRG1 (an SGK3 substrate). | ||||
| GC62431 | SGK1-IN-2 | 1426214-64-3 | >98.00% | |
SGK1-IN-2 (14h) is a selective SGK1 (serum and glucocorticoid regulated kinase 1) inhibitor, with an IC50 of 5 nM at 10 μM ATP concentration. | ||||
| GC64706 | SGK1-IN-4 | 1628048-93-0 | >99.50% | |
SGK1-IN-4 (compound 17a) is a highly selective, orally active SGK1 inhibitor. | ||||
| GC73088 | SGK1-IN-3 hydrochloride | - | >96.00% | |
SGK1-IN-3 drochloride (compound 3a) is a potent and orally active inhibitor of SGK1. | ||||
| GC73111 | HaloPROTAC-E | 2365478-58-4 | >99.00% | |
HaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM | ||||
